Sweden's Aplex Bio Gearing up to Launch 'Hyperplexed' PCR Platform
Aplex Bio believes its technology has the sensitivity, specificity, and scale to challenge both digital PCR and next-generation sequencing-based applications.
Source: genomeweb.com